retatrutide injections for weight loss: Study shows 30% body weight loss How to Inject Retatrutide -

Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial

Dig Dis Sci 1993

Limited generalizability to modern practice: low use of SGLT2i and GLP-1 RA

Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer

However, the effect of probiotic intake on intestinal mucosa is not necessarily fixed and is related to the host and its microbiome characteristics (112)

Safety concerns were also raised in a phase 1 trial investigating the GLP-1R/GCGR agonist NNC9204-117, where a dose-dependent increase in heart rate was observed, in addition to increased markers of inflammation, hepatic disturbances, impaired glucose tolerance, and reduced blood levels of some amino acids despite clinically relevant weight loss (Friedrichsen et al